Pediatric Anesthesia - PowerPoint PPT Presentation

About This Presentation
Title:

Pediatric Anesthesia

Description:

Title: Pediatric Anesthesia Author: Darko Vodopich Last modified by: Apple Created Date: 2/25/2003 1:43:20 AM Document presentation format: On-screen Show (4:3) – PowerPoint PPT presentation

Number of Views:752
Avg rating:3.0/5.0
Slides: 70
Provided by: Dark73
Category:

less

Transcript and Presenter's Notes

Title: Pediatric Anesthesia


1
Pediatric Anesthesia
Presented May 2003
  • Abdulaziz Hisham Al Gain

2
  • Development
  • Organogenesis - 1st 8 weeks
  • Organ function - 2nd trimester
  • Body mass - 3rd trimester

3
  • Changes in cardiovascular system
  • Removal of placenta from circulation
  • Increasing of systemic vascular resistance
  • Decreasing of pulmonary vascular resistance
  • True closure of PDA 2-3 weeks ? critical
    transitional circulation
  • Myocardial cell mass less developed ? prone to
    biventricular failure, volume loading, poor
    tolerance to afterload, heart rate-dependent
    CO
  • True for young infants

4
  • Changes in pulmonary system
  • Small airway diameter - increased resistance
  • Little support from the ribs
  • VO2 2x gt adults
  • Diaphragm and intercostal muscles do not achieve
    type-1 adult muscle fibers until age 2
  • Obligate nasal breathers

5
  • Airway difference
  • Large tongue
  • Higher located larynx
  • Epiglottis short and stubby, angled over the
    inlet
  • Angled vocal cords ? we must rotate ETT to
    correct lodging at anterior comissure
  • Narrowest portion is cricoid cartilage

6
  • Chest wall/Respiratory difference
  • Ribs are horizontal in neonates (vertical in
    adults)
  • Ribs and cartilages are more pliable
  • Chest wall collapse more with increased negative
    intrathoracic pressure
  • Atelectasis is more common
  • ? FRC
  • ? number of alveoli
  • Alveolar ventilation/FRC
  • Adults 1.51
  • Infants 51 (? respiratory rate)

7
  • Kidney and liver difference
  • Low renal perfusion pressure, immature GF, TF,
    obligate Na loser in the 1st month of life
  • Complete maturation _at_ 2 years of age
  • Impaired liver enzymes, including conjugation
    react.
  • Lower levels of albumen and proteins - prone to
    neonatal coagulopathy, and less drug bound ?
    higher drug levels

8
  • GI system and thermoregulation
  • Full coordination of swallowing 4-5 months ?
    increased risk for GE reflux
  • Large body surface area/weight
  • Limited ability to cope stress
  • Minimal ability to shiver in 1st 3 months
  • Heat whole body including the head

9
  • Pharmacology/dynamics
  • Increased total body water
  • Large initial dose required
  • Less fat ? longer clinical drugs effect
  • Redistribution of the drug into muscle will
    increase duration of clinical effect (fentanyl)
  • Consider liver and kidney immaturity

10
  • Volatile anesthetics
  • Isoflurane
  • Less myocardial depression than Halothane
  • Preservation of heart rate
  • CMRO2 reduction rate
  • Desflurane
  • Increased incidence of coughing, laryngospasm,
    secretions
  • Concern of hypertension and tachycardia from
    sympathetic activation

11
  • Volatile anesthetics (2)
  • Sevoflurane
  • Less pungent than Isoflurane
  • Concern of compound A (nephrotoxicity)
  • Most suitable for induction
  • Remember MAC for potent volatile anesthetics is
    increased in neonates, but may be lower for
    sicker neonates and premies

12
  • Induction drugs
  • Methohexital
  • 1-2 mg/kg i.v. or 25-30 mg/kg per rectum
  • Side effects
  • burning
  • hiccup
  • apnea
  • extrapyramidal syndrome
  • Contraindication temporal lobe epilepsy
  • Thiopental
  • 5-6 mg/kg i.v.
  • Caution in low fat children and malnourished

13
  • Induction drugs
  • Propofol
  • 3 mg/kg i.v. (until 6 years of age)
  • Pain on injection - 0.2 mg/kg Lidocaine i.v.
  • Ketamine
  • 10 mg/kg IM, PR, orally
  • Increased salivation
  • Contraindications Increased ICP
  • Open globe injury

14
  • Induction drugs
  • Benzodiazepines
  • Diazepam
  • 0.1-0.3 mg/kg orally
  • T1/2 80 hours ? contraindicated lt 6 months
  • Midazolam
  • Only FDA benzodiazepine approved in neonates
  • 0.1-0.15 mg/kg IM
  • 0.5-0.75 mg/kg orally
  • 0.75-1.0 mg/kg rectally
  • Reduce dose in drugs ? cause Cytochrome P- 450
    inhibition

15
  • Induction drugs
  • Narcotics
  • Morphine
  • Increased permeability of blood/brain barrier
  • 50 mcg/kg IV
  • Meperidine
  • Less respiratory depression than morphine
  • Be cautious in long term administration because
    of its metabolite normeperidine

16
  • Induction drugs
  • Narcotics(2)
  • Fentanyl
  • 12.5 mcg/kg IV during induction provides stable
    cardiovascular response
  • 1-2 mcg/kg adjuvant to anesthesia
  • Stable cardiovascular response
  • Alfentanyl and Sufentanyl
  • More rapid clearance than adults
  • Can cause parasympatholysis ? bradycardia,
    hypotension

17
  • Induction drugs
  • Muscle relaxants
  • Succinylcholine
  • 2.0 mg/kg IV 4.0 mg/kg IM
  • Consider Atropine 10-15 mcg/kg given prior SUX
  • Potential side effects
  • Rhabdomyolysis
  • Hyperkalemia
  • Masseter spasm
  • MH

18
  • Induction drugs
  • Muscle relaxants(2)
  • If tachycardia desired - Pancuronium
  • Mivacurium - brief surgeries, beware of
    histamine release, bronchospasm
  • Rocuronium - useful for modified RSI, and can
    be administered IM (1 mg/kg)

19
Muscle relaxants - Summary
20
  • Premedication
  • Almost all sedatives are effective
  • Usually not necessary lt 6 months
  • Most common route used is oral
  • Side effects
  • Oral - slow onset
  • IM - pain, sterile abscess
  • Rectal - uncomfortable, defecation, burn
  • Nasal -irritating
  • Sublingual -bad taste

21
  • Pharmacological premedication options
  • Role when awake separation of child from parent
    before induction is planned.
  • Its success may be judged by the peacefulness of
    the separation.
  • Large volume of literature indicates lack of
    clearly ideal technique

http//metrohealthanesthesia.com/edu/ped/pedspreop
6.htm
22
  • Pharmacological premedication options
  • Midazolam (Versed)
  • PO 0.5 to 1.0 mg/kg up to 10 mg max.
  • Bioavailability 30
  • Peak serum levels after about 45 minutes
  • Peak sedation by about 30 minutes
  • 85 peaceful separation
  • Mix with grape concentrate or acetaminophen
    (Tylenol) syrup or elixir or Motrin Suspension
    (10 mg/kg of the 2 suspension)

23
  • Pharmacological premedication options (3)
  • Midazolam (Versed)(2)
  • Nasal 0.2 to 0.6 mg/kg
  • Peak serum level in 10 minutes
  • 0.2 mg/kg same as 0.6 mg/kg except
  • 0.2 mg/kg did not delay recovery
  • 0.6 mg/kg may delay extubation
  • Possible concern animal studies reveal
    neurotoxicity after topical applicaton.

24
  • Pharmacological premedication options (4)
  • Midazolam (Versed)(3)
  • Sublingual 0.2-0.3 mg/kg as effective as 0.2
    mg/kg intranasal
  • Rectal 0.35 to 1.0 mg/kg
  • Some effect by 10 minutes, peak effect 20-30
    minutes.
  • 1.0 mg/kg did not delay PACU discharge.

25
  • Pharmacological premedication options (5)
  • Methohexital (Brevital)
  • Rectal 25 to 30 mg/kg as 10 solution in warm
    tap water
  • 85 sleeping within 10 minutes rectal
    induction of GA (very peaceful separation)
  • Sleep duration about 45 to 90 minutes
  • 25 mg/kg did not delay recovery in one study, but
    some delay may be expected after a short (less
    than 30-minute) case.

26
  • Pharmacological premedication options (6)
  • Ketamine
  • PO 6 to 10 mg/kg
  • May slightly prolong time to discharge after a
    short case
  • IM 3 to 4 mg/kg sedation
  • 2 mg/kg did not delay recovery
  • 6 to 10 mg/kg IM induction of general
    anesthesia
  • 10 mg/kg as effective as Midazolam 1 mg/kg but
    some delay in recovery may be expected

27
  • Pharmacological premedication options (7)
  • Midazolam Ketamine
  • PO 0.4 mg/kg 4 mg/kg respectively
  • 100 successful separation
  • 85 easy mask induction
  • Doubling dose leads to "oral induction of general
    anesthesia" in most cases. Lasts 30 to 60
    minutes.

28
  • Pharmacological premedication options (8)
  • Fentanyl "lollipops" (oral transmucosal Fentanyl)
  • 15 to 20 mcg/kg
  • Increased volume of gastric contents
  • Nausea and vomiting
  • Pruritus
  • Hypoventilation (SpO2 lt90)

29
  • Pharmacological premedication options (9)
  • Metoclopramide (Reglan) PO or IV 0.2 mg/kg
  • Ranitidine (Zantac) PO 2.5 mg/kg
  • EMLA cream Eutectic mixture of Lidocaine and
    Prilocaine. For cutaneous application by
    occlusive dressing one hour preoperative
  • Glycopyrrolate consider for selected patients
    for planned airway instrumentation e.g.
    fiberoptic endoscopy, oral or upper airway
    surgery, cleft palate)5-10 mcg/kg IV or 10
    mcg/kg IM

30
(No Transcript)
31
  • Fasting
  • Clear liquids - 2-3 h before the procedure
  • If infants are breast fed - 4 h before the
    procedure
  • For older patients the adults rule
  • Be aware of dehydration

32
  • Induction of Anesthesia
  • Inhalational induction
  • Younger than 12 months
  • After the induction, place the intravenous
    catheter
  • Use suggestions in older child (pilots mask)
  • In a case of difficult airway - Fiberoptic
    intubation

33
  • Induction of Anesthesia
  • Rectal induction
  • Methohexital
  • Thiopental
  • Ketamine
  • Midazolam
  • Technique no more intimidating than rectal
    temperature measurement
  • Usual time of onset 10-15 min

34
  • Induction of Anesthesia
  • Intramuscular induction
  • Most common used Ketamine
  • Disadvantage painful needle insertion
  • Advantage reliability

35
  • Induction of Anesthesia
  • Intravenous induction
  • The most reliable and rapid technique
  • Disadvantage - starting intravenous line
  • If patient is older ask the patient
  • If you insert IV line
  • I. Do not allow the patient to see it
  • II. Use EMLA cream
  • III. If use local - ask the patient if there is
    any sensation on puncture

36
  • Patient with full stomach
  • Treat the same as adult with full stomach
  • RSI with ODL using cricoid pressure
  • Tell the patient that will feel touching on the
    neck
  • Be aware of ? VO2 (desaturation)
  • 0.02 mg/kg of Atropine administer before SUX to
    avoid bradycardia (usually after 2nd dose)
  • Use Rocuronium 1.2 mg/kg
  • Use Succinylcholine 1-2 mg/kg ? if really need
    short duration (difficult airway)

37
Endotracheal tubes
4 (1/4) (age) size 12 (1/2)
(age) depth
38
Intravenous fluids
Include if present Fluid deficits Third spaces
losses Hypo/hyperthermia Unusual metabolic
fluids demands
39
  • Fluid requirements in neonates
  • During the 1st week reduced fluid requirements
  • Day 1 - 70 ml/kg
  • Day 3 - 80 ml/kg
  • Day 5 - 90 ml/kg
  • Day 7 - 120 ml/kg
  • Concern is immaturity of the neonatal kidney
  • The volume of extracellular fluids in neonates
    is large
  • Consider use of radiant warmers, and heated
    humidifiers - decrease insensible water loss
  • Use LR for replacement, D5 with 0.45 NS by
    piggyback

40
  • Packed Red Blood Cells
  • The use has diminished because of disease
    transmission (HIV, Hep C,B. etc)
  • Blood volume
  • Premature infant - 100 -120 ml/kg
  • Full-term infant - 90 ml/kg
  • 3-12 month old child - 80 ml/kg
  • 1 year and older child - 70 ml/kg
  • EBV (starting Hct - target Hct)
  • MABL
  • Starting Hct

41
  • Packed Red Blood Cells (2)
  • Child usually tolerates Hct 20 in mature
    children
  • If
  • Premature,
  • Cyanotic congenital disease Hct 30
  • ? O2 carrying capacity
  • No one formula permits a definitive decision
  • Replace 1ml blood with 3 ml of LR
  • Lactic acidosis is a late sing of decreased O2
    carrying capacity
  • Be aware of blood disorders (sickle cell disease)

42
  • Fresh Frozen Plasma
  • Use to replenish clotting factors during massive
    transfusion, DIC, congenital clotting factor
    deficits
  • Usually replenished if EBL 1-1.5 TBV
  • A patient should be never given FFP to replace
    bleeding that is surgical in nature
  • If transfused faster than 1.0 ml/kg/min severe
    ionized hypocalcemia may occur
  • If occurs - Rx. with 7.5-15 mg/kg Ca gluconate
  • Ionized hypocalcemia can occur in neonates
    frequently because of decreased ability to
    mobilize Ca and metabolize citrate

43
Ionized Hypocalcemia
44
  • Platelets
  • Find etiology - TTP, ITP, HIT, DIC, hemodilution
    after massive blood transfusion
  • Consider transfusion if Platelets lt 50.000
  • In certain hospitals platelet function test is
    available
  • If Platelets lt 100.000 and EBL 1-2 TBV -
    transfusion more likely
  • If Platelets gt 150.000 and EBL gt 2 TBV
    transfusion more likely

45
  • Monitoring the Pediatric Patients
  • Must be consistent with the severity of the
    underlying medical condition
  • Minimal monitoring
  • I. 5 ASA monitors
  • II. Precordial stethoscope
  • III. Anesthetic agent analyzer
  • Use of capnograph and O2 analyzers is associated
    with high incidence of false alarms from
  • movement artifact
  • light interference
  • electrocautery

46
Special Monitoring the Pediatric Patients
  • Intraarterial catheter - most common radial
  • Pulmonary artery catheters are rarely indicated
    because equalization of the pressure right/left
    heart
  • In a case of severe multisystem organ failure
    insertion of PAC might be particularly useful
  • Multilumen catheters are valuable in ICU
    patients
  • In a case of rapid fluid replacement peripheral
    venous catheter might be very useful
  • Short-term cannulation of femoral/brachiocephalic
    or umbilical vein may be life-saving

47
  • Anesthesia Circuits
  • Nonrebreathing circuits
  • 1. Minimal work of breathing
  • 2. Speeds-up rate of inhalational induction
  • 3. Compression and compliance volumes are
    less (small circuit volume)
  • Use of Mapleson D system is recommended in
    children lt 10 kg
  • More sensitive to changes in gas flow
  • More sensitive to humidification
  • Actual delivered volume is greater than other
    systems

48
Mapleson D Circuit
Gas disposition at end-expiration during
spontaneous ventilation
Gas disposition at controlled ventilation
49
  • Neonatal Anesthesia
  • Understand differences in
  • Physiology
  • Pharmacology
  • Pharmacodynamic response
  • Most of the complications that arise are
    attributable to a lack of understanding of these
    special considerations prior to induction of
    anesthesia
  • Be aware of
  • Sudden changes in hemodynamics
  • Unexpected responses
  • Unknown congenital problem

50
  • Neonatal Anesthesia (2)
  • Children lt 1 year old have more complications
  • I. Oxygenation
  • II. Ventilation
  • III. Airway management
  • IV. Response to volatile agents and medications
  • Stress response is poorly tolerated
  • Consider
  • 1. Organ system immaturity
  • 2. High metabolic rate
  • 3. Large ratio body surface/weight
  • 4. Ease of miscalculating a drug dose

51
  • Neonatal Anesthesia (3)
  • Prevention of paradoxical air emboli
  • Fluids instituted with volume-limiting devices
  • Minimize thermal stress
  • Use flow-through capnograph if possible
  • Prevent retinopathy of prematurity by
  • Lower FiO2
  • Keep CO2 within normal range

52
  • Neonatal Anesthesia (4)
  • Stress Response
  • Poorly tolerated
  • Use opioid technique (blunt pain response)
  • Ketamine is excellent choice stable
    intraoperative hemodynamics
  • Potent volatile anesthetics are poorly tolerated
  • No one should be denied anesthesia because of
    the age or weight

53
  • Special Problems in Neonatal Anesthesia
  • Meningomyelocele
  • Underestimating fluid or blood loss from the
    defect
  • High association with hydrocephalus
  • Possibility of cranial nerve palsy
  • Potential for brain-stem herniation

54
  • Special Problems in Neonatal Anesthesia (2)
  • Pyloric stenosis
  • First 3-6 weeks in life
  • Anesthesiologist concern
  • I. Full stomach with barium
  • II. Metabolic alkalosis with
  • Hypochloremia and Hypokalemia
  • III. Severe dehydration
  • Surgery is never emergency
  • Metabolic correction mandatory before the
    surgery
  • Suction the stomach before induction
  • Consider awake intubation or RSI

55
  • Special Problems in Neonatal Anesthesia (3)
  • Omphalocele and Gastroschisis
  • Omphalocele occurs because of failure of the gut
    to return to the abdominal cavity at 10th week
    of life
  • Fine membrane covers intestines and abdominal
    contents
  • Gastroschisis develops later in life after gut
    has returned into abdominal cavity
  • Abdominal contents and organs are not covered
    with any membrane risk of infection

56
  • Special Problems in Neonatal Anesthesia (3)
  • Omphalocele

57
  • Special Problems in Neonatal Anesthesia (3)
  • Gastroschisis

58
  • Special Problems in Neonatal Anesthesia (3)
  • Omphalocele and Gastroschisis(2)
  • Anesthesiology concern
  • 1. Dehydration
  • 2. Massive fluid loss (exposed
  • viscera and 3rd space loss)
  • 3. Heat loss
  • 4. Difficulty of surgical closure
  • 5. High association with prematurity, congenital
    defects, including cardiac anomalies
  • Minimize infection, Replenish fluids, be liberal
    in muscle relaxants, consider hypotension and
    difficulty ventilation

59
  • Special Problems in Neonatal Anesthesia (3)
  • Omphalocele and Gastroschisis(3)
  • During closure consider
  • difficulty ventilation
  • hypotension
  • ? abdominal pressure may compromise liver
    function and alter drug metabolism
  • During closure of big defects monitoring of the
    bladder pressures is important if the pressure
    is
  • lt 20 cm H2O attempt is to close, gt 20 cm H2O
    closing in stages.

60
  • Special Problems in Neonatal Anesthesia(3)
  • Omphalocele and Gastroschisis (4)
  • Be aware of Beckwith-Wiedemann syndrome
  • Profound hypoglycemia
  • Hyperviscosity syndrome
  • Associated visceromegaly

61
  • Special Problems in Neonatal Anesthesia(3)
  • Omphalocele and Gastroschisis ddx. (5)
  • Much greater associated defects with Omphalocele
  • More fluid loss associated with Gastroschisis

62
  • Special Problems in Neonatal Anesthesia(4)
  • Tracheoesophageal fistula anomaly(1)
  • 90 proximal atresia of esophagus
  • with distal fistula
  • Consider aspiration pneumonitis.
  • VATER syndrome
  • I. Vertebral
  • II. Anal
  • III. Tracheoesophageal
  • IV. Renal
  • MCC of death cardiac anomalies

63
  • Special Problems in Neonatal Anesthesia(4)
  • Tracheoesophageal fistula anomaly(1)
  • 90 proximal atresia of esophagus
  • with distal fistula
  • Consider aspiration pneumonitis.
  • VATER syndrome
  • I. Vertebral
  • II. Anal
  • III. Tracheoesophageal
  • IV. Renal
  • MCC of death cardiac anomalies

64
  • Special Problems in Neonatal Anesthesia(4)
  • Tracheoesophageal fistula anomaly(2)
  • Major issues are
  • Aspiration pneumonia
  • Overdistention of the stomach
  • Inability to ventilate
  • Postoperative intensive care

65
  • Special Problems in Neonatal Anesthesia (4)
  • Tracheoesophageal fistula anomaly(3)
  • Induction
  • Awake intubation
  • Deliberate right main stem intubation
  • Catheter in esophagus
  • Prone position with head-up
  • Avoid massive distention of the stomach
  • by gentle ventilation
  • Careful confirmation of tube position
  • by moving tube mm by mm (position must be
    between fistula and tracheal bifurcation)
  • Tape precordial stethoscope over the left chest

66
  • Special Problems in Neonatal Anesthesia (5)
  • Diaphragmatic hernia
  • Usually presentation on
  • 1st day of life
  • Almost all viscera can be in the
  • chest cavity
  • Anesthesia concerns
  • I. Hypoxemia
  • II. Hypotension
  • III. Stomach herniation
  • IV. Pulmonary hypertension
  • V. Systemic hypotension

Shifted mediastinum
Diaphragmatic hernia
67
  • Special Problems in Neonatal Anesthesia (5)
  • Diaphragmatic hernia (2)
  • 1. Awake intubation
  • 2. Intraarterial catheter
  • 3. Use opioids (stress response)
  • 4. Use Pancuronium
  • 5. Avoid hypothermia
  • 6. Avoid any myocardial depressant
  • 7. Avoid N2O (abdominal distention)
  • 8. Aware of barotrauma-induced pneumothorax
  • 9. Adequate intravenous access
  • 10. Plan postoperative care

Shifted mediastinum
Diaphragmatic hernia
68
  • Special Problems in Neonatal Anesthesia (6)
  • Former preterm infant (lt37 weeks)
  • High incidence of apnea risk factors Respirato
    ry distress syndrome
  • Bronchopulmonary dysplasia
  • Neonatal dyspnea
  • Necrotizing enterocolitis
  • Ongoing apnea at the time of surgery
  • Use of narcotics
  • Long acting muscle relaxants
  • Anemia (Hct lt 30)

69
  • Regional Anesthesia and Anesthesia
  • (brief overview)
  • Most regional anesthetics are safe to use
  • Strict attention to
  • Dose
  • Route of administration
  • Proper equipment used
  • Common
  • Caudal blocks
Write a Comment
User Comments (0)
About PowerShow.com